AllianceBernstein
PCVX icon

AllianceBernstein’s Vaxcyte PCVX Stock Holding History

AllianceBernstein’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.29M Buy
159,909
+22,827
+17% +$1.24M ﹤0.01% 1231
2026
Q1 		$6.32M Buy
137,082
+3,200
+2% +$174K ﹤0.01% 1427
2025
Q4 		$6.18M Sell
133,882
-1,344
-1% -$60.1K ﹤0.01% 1438
2025
Q3 		$4.87M Sell
135,226
-6,260
-4% -$207K ﹤0.01% 1532
2025
Q2 		$4.6M Sell
141,486
-1,562,725
-92% -$51.2M ﹤0.01% 1512
2025
Q1 		$64.4M Sell
1,704,211
-75,151
-4% -$6.01M 0.02% 513
2024
Q4 		$146M Buy
1,779,362
+133,448
+8% +$13.3M 0.05% 288
2024
Q3 		$188M Sell
1,645,914
-88,907
-5% -$8.01M 0.06% 236
2024
Q2 		$131M Sell
1,734,821
-45,882
-3% -$3.12M 0.05% 307
2024
Q1 		$122M Sell
1,780,703
-134,344
-7% -$9.3M 0.04% 359
2023
Q4 		$120M Sell
1,915,047
-28,783
-1% -$1.49M 0.05% 348
2023
Q3 		$99.1M Buy
1,943,830
+55,724
+3% +$2.75M 0.04% 382
2023
Q2 		$94.3M Buy
1,888,106
+1,804,718
+2,164% +$85.5M 0.04% 405
2023
Q1 		$3.13M Buy
83,388
+9,700
+13% +$411K ﹤0.01% 1623
2022
Q4 		$3.53M Buy
73,688
+28,488
+63% +$1.12M ﹤0.01% 1590
2022
Q3 		$1.08M Hold
45,200
– – ﹤0.01% 2241
2022
Q2 		$984K Buy
45,200
+1,200
+3% +$27.8K ﹤0.01% 2352
2022
Q1 		$1.06M Buy
44,000
+6,900
+19% +$151K ﹤0.01% 2410
2021
Q4 		$883K Hold
37,100
– – ﹤0.01% 2515
2021
Q3 		$941K Buy
37,100
+6,900
+23% +$167K ﹤0.01% 2516
2021
Q2 		$680K Buy
30,200
+7,800
+35% +$160K ﹤0.01% 2687
2021
Q1 		$442K Sell
22,400
-4,000
-15% -$101K ﹤0.01% 2715
2020
Q4 		$701K Hold
26,400
– – ﹤0.01% 2440
2020
Q3 		$1.3M Buy
+26,400
New +$1.05M ﹤0.01% 2065

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AllianceBernstein's PCVX Position: Q2 2026 in Review

AllianceBernstein increased its Vaxcyte (PCVX) stake by 17% in Q2 2026, buying an estimated $1.24M and bringing the position to 159,909 shares worth $9.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

AllianceBernstein first reported a position in PCVX in Q3 2020 and has held it in 24 quarters since. The position peaked at $188M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • AllianceBernstein held 159,909 shares of Vaxcyte worth $9.29M as of Q2 2026.
  • AllianceBernstein bought 22,827 Vaxcyte shares in Q2 2026, an estimated $1.24M.
  • Vaxcyte made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1231 holding.
  • AllianceBernstein first reported a position in Vaxcyte in Q3 2020 and has held it in 24 quarters since.
  • AllianceBernstein's Vaxcyte position peaked at $188M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.